SOLENO THERAPEUT. DL-001 (6XC) — Capital Reinvestment Ratio
Latest as of December 2025:
0.00x
SOLENO THERAPEUT. DL-001 (6XC) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow (€48.70 Million) in capital expenditures (€58.00K). See 6XC free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
€48.70 Million
EUR
Capital Expenditures
€58.00K
EUR
Data as of
Dec 2025
Most recent filing
SOLENO THERAPEUT. DL-001 Capital Reinvestment Ratio (2025–2025)
This chart tracks SOLENO THERAPEUT. DL-001's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for SOLENO THERAPEUT. DL-001 (2025–2025)
Year-by-year Capital Reinvestment Ratio for SOLENO THERAPEUT. DL-001 from 2025 to 2025. For live market cap and broader valuation context, see market value of SOLENO THERAPEUT. DL-001.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | €46.80 Million | €73.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow